Patent classifications
C12R2001/37
BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF A BRANCHED CHAIN AMINO ACID
The present disclosure provides recombinant bacterial cells that have been engineered with genetic circuitry which allow the recombinant bacterial cells to sense a patient's internal environment and respond by turning an engineered metabolic pathway on or off. When turned on, the recombinant bacterial cells complete all of the steps in a metabolic pathway to achieve a therapeutic effect in a host subject. These recombinant bacterial cells are designed to drive therapeutic effects throughout the body of a host from a point of origin of the microbiome. Specifically, the present disclosure provides recombinant bacterial cells comprising a heterologous gene encoding a branched chain amino acid catabolism enzyme. The disclosure further provides pharmaceutical compositions comprising the recombinant bacteria, and methods for treating disorders involving the catabolism of branched chain amino acids using the pharmaceutical compositions disclosed herein.
<i>Klebsiella pneumoniae </i>strain inducing inflammation in liver
To identify a microorganism causing the development of primary sclerosing cholangitis associated with ulcerative colitis. A Klebsiella pneumoniae strain inducing inflammation in the liver.
KLEBSIELLA PNEUMONIAE STRAIN INDUCING INFLAMMATION IN LIVER
To identify a microorganism causing the development of primary sclerosing cholangitis associated with ulcerative colitis. A Klebsiella pneumoniae strain inducing inflammation in the liver.
KLEBSIELLA PNEUMONIAE STRAIN INDUCING INFLAMMATION IN LIVER
To identify a microorganism causing the development of primary sclerosing cholangitis associated with ulcerative colitis. A Klebsiella pneumoniae strain inducing inflammation in the liver.
<i>Klebsiella pneumoniae </i>strain inducing inflammation in liver
To identify a microorganism causing the development of primary sclerosing cholangitis associated with ulcerative colitis. A Klebsiella pneumoniae strain inducing inflammation in the liver.
Method for biodegrading high molecular weight polycyclic aromatic hydrocarbon pyrenes with halophilic bacteria
A method and composition for biodegrading or bioremediating a pyrene or other polycyclic aromatic hydrocarbon (PAH) with one or more bacteria of the genus Halomonas or Idiomarina. Bacterial strains useful for degrading or remediating pyrenes and other polycyclic aromatic hydrocarbons.
KLEBSIELLA PNEUMONIAE STRAIN THAT INDUCES INFLAMMATION IN THE LIVER
To identify a microorganism causing the development of primary sclerosing cholangitis associated with ulcerative colitis. A Klebsiella pneumoniae strain inducing inflammation in the liver.
METHOD FOR BIODEGRADING HIGH MOLECULAR WEIGHT POLYCYCLIC AROMATIC HYDROCARBON PYRENES WITH HALOPHILIC BACTERIA
A method and composition for biodegrading or bioremediating a pyrene or other polycyclic aromatic hydrocarbon (PAH) with one or more bacteria of the genus Halomonas or Idiomarina. Bacterial strains useful for degrading or remediating pyrenes and other polycyclic aromatic hydrocarbons
Cellulose production by facultatively anaerobic microorganisms
A method for producing bacterial cellulose, said method comprising culturing a biologically pure culture of a cellulose-producing Proteus strain in a liquid medium suitable for culturing facultatively anaerobic microorganisms, separating bacterial cellulose produced in said liquid medium from said liquid medium, washing said separated bacterial cellulose and drying said bacterial cellulose. The cellulose-producing Proteus strain is preferably a Proteus myxofaciens strain, preferably strain IDAC 071005-01 or strain ATCC 19692. The liquid medium is provided with a carbohydrate substrate containing at least one sugar selected from the group consisting of glucose, sucrose, fructose, lactose, xylose, and rhamnose. A bacterial cellulose product produced by culturing a biologically pure culture of a cellulose-producing Proteus strain in a liquid medium suitable for culturing facultatively anaerobic microorganisms.
CELLULOSE PRODUCTION BY FACULTATIVELY ANAEROBIC MICROORGANISMS
A method for producing bacterial cellulose, said method comprising culturing a biologically pure culture of a cellulose-producing Proteus strain in a liquid medium suitable for culturing facultatively anaerobic microorganisms, separating bacterial cellulose produced in said liquid medium from said liquid medium, washing said separated bacterial cellulose and drying said bacterial cellulose. The cellulose-producing Proteus strain is preferably a Proteus myxofaciens strain, preferably strain IDAC 071005-01 or strain ATCC 19692. The liquid medium is provided with a carbohydrate substrate containing at least one sugar selected from the group consisting of glucose, sucrose, fructose, lactose, xylose, and rhamnose. A bacterial cellulose product produced by culturing a biologically pure culture of a cellulose-producing Proteus strain in a liquid medium suitable for culturing facultatively anaerobic microorganisms.